FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092890 [Registered on: 12/08/2025] Trial Registered Prospectively
Last Modified On: 13/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial on the effectiveness of Brahmi Ghrita and Saraswata churna in children with Attention Deficit Hyperactivity Disorder aged 6-12 years in a sample of 21 individuals 
Scientific Title of Study   Effect of Brahmi Ghrita and Saraswata Churna in Children with Attention Deficit Hyperactivity Disorder aged 6-12 years 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pooja Rose CJ 
Designation  MD SCHOLAR 
Affiliation  Govt. Ayurveda College Thiruvananthapuram 
Address  Department of Kaumarabhritya, Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala 695012 India

Thiruvananthapuram
KERALA
695012
India 
Phone  9567362633  
Fax    
Email  poojarosechelakkara26@gmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr Sohini S 
Designation  Associate Professor 
Affiliation  Govt Ayurveda College Thiruvananthapuram 
Address  Department of Kaumarabhritya, Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala 695012 India

Thiruvananthapuram
KERALA
695012
India 
Phone  9447657471  
Fax    
Email  drsohini30@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sohini S 
Designation  Associate Professor 
Affiliation  Govt Ayurveda College Thiruvananthapuram 
Address  Department of Kaumarabhritya, Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala 695012 India

Thiruvananthapuram
KERALA
695012
India 
Phone  9447657471  
Fax    
Email  drsohini30@gmail.com  
 
Source of Monetary or Material Support  
Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala , 695012, India 
 
Primary Sponsor  
Name  Dr Pooja Rose CJ 
Address  Department of Kaumarabhritya, Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala , 695012, India 
Type of Sponsor  Other [Govt. Ayurveda College Thiruvananthapuram] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pooja Rose CJ  Govt. Ayurveda College Thiruvananthapuram, Women and Children Hospital Poojappura  Department of Kaumarabhritya, Govt. Ayurveda College Women and Children Hospital Poojappura, Thiruvananthapuram Kerala
Thiruvananthapuram
KERALA 
09567362633

poojarosechelakkara26@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE, GOVT. AYURVEDA COLLEGE THIRUVANANTHAPURAM(IEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F902||Attention-deficit hyperactivity disorder, combined type. Ayurveda Condition: UNMADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: BRAHMI GHRITA , Reference: Ashtanga Hrdaya Uttarasthana Unmada Prathishedha, Route: Oral, Dosage Form: Ghrita, Dose: 200(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Lukewarm Water), Additional Information: -
(2) Medicine Name: SARASWATA CHURNA , Reference: Bhaishajya Ratnavali Unmada Chikitsa, Route: Oral, Dosage Form: Churna/ Powder, Dose: 100(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Honey), Additional Information: -
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  i. Children diagnosed with Attention Deficit Hyperactivity Disorder of the age group of 6 to 12 years according to DSM-5 criteria 
 
ExclusionCriteria 
Details  i. Presence of any other psychiatric comorbidity.
ii. Presence of any other organic problem or brain damage
iii. Diagnosed cases of mental retardation
iv. Patients with other diagnosed genetic disorders
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in features of Attention Deficit Hyperactivity Disorder assessed using the ADHDT-2 scale
and Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS).
 
Assessment of ADHD features before and after study and after follow- up will be done by using the ADHDT-2 scale and the Vanderbilt ADHD diagnostic parent rating scale (VADPRS). 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="21"
Sample Size from India="21" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Children with an age group of 6- 12 years satisfying the DSM 5 criteria for ADHD will be selected for the study from the OPD of Government Ayurveda College Hospital for Women and Children, Poojappura, Informed consent will be taken from the parents of the selected participants. The participants in the study group will be made fit to take the ghrita yoga after administering ashtachurna [age-appropriate dose] having Deepana-pachana property for the correction of Agni, for a period of 5 days. Then the participants will be administered with Brahmi Ghrita in age-appropriate dose twice daily with lukewarm water as anupana before food and Saraswata Churna in age-appropriate dose twice daily with honey as anupana after food depending upon the age of the child. They will be advised on dietary regulations for ADHD. Assessment of ADHD features before and after study and after follow- up will be done by using the ADHDT-2 scale and the Vanderbilt ADHD diagnostic parent rating scale (VADPRS). Trial drug will be given for sixty days. Further, the data will be collected, scored, and statistically analyzed using appropriate statistical techniques.

 
Close